P3 Health Partners
PIII
13 hedge funds and large institutions have $1.03M invested in P3 Health Partners in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
1.1% less ownership
Funds ownership: 10.05% → 8.94% (-1.1%)
13% less funds holding
Funds holding: 15 → 13 (-2)
65% less capital invested
Capital invested by funds: $2.95M → $1.03M (-$1.93M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corient Private Wealth
Miami,
Florida
|
+$42.6K |
| 2 |
TFA
Trinity Financial Advisors
Columbus,
Ohio
|
+$13.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.97K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.53K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$294K |
| 2 |
JP Morgan Chase
New York
|
-$6.76K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.05K |
| 4 |
Barclays
London,
United Kingdom
|
-$590 |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$298 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Alyeska Investment Group
Chicago,
Illinois
| $480K | -$294K | -43,500 | -24% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $168K | -$4.05K | -599 | -1% |
|
|
3
Corient Private Wealth
Miami,
Florida
| $145K | +$42.6K | +6,305 | +18% |
|
|
TFA
4
Trinity Financial Advisors
Columbus,
Ohio
| $100K | +$13.4K | +1,979 | +7% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $74.9K | +$6.97K | +1,031 | +5% |
|
6
BlackRock
New York
| $37.2K | +$818 | +121 | +1% |
|
7
William Blair & Company
Chicago,
Illinois
| $10.8K | -$27 | -4 | -0.1% |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4.79K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $3.32K | +$5.53K | +817 | +610% |
|
|
10
Bank of America
Charlotte,
North Carolina
| $1.75K | +$3.38K | +500 | +50,000% |
|
|
11
BNP Paribas Financial Markets
Paris,
France
| $126 | -$298 | -44 | -55% |
|
|
12
JP Morgan Chase
New York
| $67 | -$6.76K | -1,000 | -98% |
|
|
13
Barclays
London,
United Kingdom
| – | -$590 | -66 | Closed |
|
14
Fidelity Investments
Boston,
Massachusetts
| – | -$37 | -4 | Closed |
|
PIII Hedge Fund Activity: Q4 2025 in Review
13 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q4 2025, worth a combined $1.03M — down 65% from $2.95M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PIII and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Corient Private Wealth, adding an estimated $42.6K. The largest seller was Alyeska Investment Group, cutting an estimated $294K.
- 13 institutional investors held P3 Health Partners (PIII) as of Q4 2025, down from 15 in Q3 2025.
- Funds reported $1.03M of P3 Health Partners stock for Q4 2025, down 65% quarter-over-quarter.
- 0 funds opened new P3 Health Partners positions in Q4 2025 and 2 closed out, a net change of -2 holders.
- The largest P3 Health Partners buyer in Q4 2025 was Corient Private Wealth, an estimated $42.6K added.
- The largest P3 Health Partners seller in Q4 2025 was Alyeska Investment Group, an estimated $294K sold.
Based on aggregated 13F filings for Q4 2025.